Mount Sinai has developed a machine learning model forecasting the cardiovascular risk impact of CPAP in obstructive sleep apnea patients.
Key Details
- 1Mount Sinai team used machine learning to analyze data from over 2,600 patients in the SAVE trial.
- 2The model estimates whether CPAP usage will benefit or harm individual cardiovascular risk profiles.
- 3Substantial differences in treatment response were discovered across patient subgroups, with up to 100-fold differences in outcomes.
- 4Model is based on 23 selected baseline predictors from over 100 sleep and health variables.
- 5Findings highlight potential for precision medicine in treating sleep apnea and associated cardiovascular risks.
Why It Matters
This study marks a step towards personalized medicine using AI, supporting tailored treatment plans in sleep medicine and cardiovascular disease. The approach underscores the value of advanced analytics in stratifying risk and improving patient outcomes, reflecting broader trends toward individualized AI-powered decision support in clinical settings.
Source
EurekAlert
Related News
•EurekAlert
AI-Doctor Disagreement May Undermine Patient Trust, Study Finds
A Penn State-led study finds that patient trust in doctors decreases when AI disagrees with their medical assessment.
•EurekAlert
Polymer-Based Flexible Wireless Sensors: AI-Driven Health Monitoring Review
A major review highlights how advanced polymer-based flexible wireless sensors, enhanced by AI-driven data processing, can transform continuous physiological health monitoring.
•EurekAlert
New Daydreaming Algorithm Boosts Neural Networks' Recall of Biased Image Data
Researchers unveil a new 'Centered Daydreaming' algorithm enabling AI to effectively learn and recall from imbalanced, real-world image data.